Species

NEWXXITEK™ HVT+ND

Get a Head Start With Early Immunity

 

 

 

Details

NEWXXITEK™ HVT+ND is an HVT-vectored vaccine with a live Marek's disease serotype 3, containing a gene insert from a Newcastle disease virus.

 

  • NEWXXITEK™ HVT+ND is a HVT-vectored vaccine

  • Contains a F gene insert from the Texas velogenic strain of NDV

  • Developed using the same technology and expertise as VAXXITEK® HVT+IBD

 

Key Advantages

  • HVT vector containing the F gene from the Texas velogenic strain of NDV

  • Same insertion site and promoter as VAXXITEK® HVT+IBD

  • Clinical protection detected as early as two weeks after vaccination1

 

Newxxitek Logo

Features & Benefits

  • Aids in the prevention of both Marek’s (equivalent to HVT) and Newcastle diseases

  • Convenient hatchery administration by subcutaneous or by in ovo vaccination

  • As safe as HVT vaccines with no live ND vaccine reaction

  • No interference with maternal antibodies

  • Seroconversion and clinical protection were detected as early as two weeks after NEWXXITEK™ HVT+ND vaccination1

  • Clinical protection reached 100% at 28 days of age2,3 

Dosage & Administration

  • Packaged in 4 x 4,000 dose ampules in frozen presentation
Resources

Contact your Boehringer-Ingelheim representative for more information.

 

Safety

  • Do not mix with other products, except as specified on the label

  • In case of human exposure, contact a physician

  • Administer only as recommended

  • Use entire contents when first opened

  • Do not vaccinate within 21 days before slaughter

  • Contains penicillin and streptomycin sulfate which are added as bacteriostatic agents

  • Contains Amphotericin B as a fungistatic agent

  • Inactivate unused contents before disposal

 

Safety Data Sheet

NEWXXITEK
References

1Data on file at Boehringer Ingelheim.

2Data on file at Boehringer Ingelheim.

3Data on file at Boehringer Ingelheim.

Trademarks

NEWXXITEK™ is a trademark of Boehringer Ingelheim Animal Health USA Inc. ©2023 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All Rights Reserved. US-POU-0061-2022

CAUTION

NEWCASTLE DISEASE CAN CAUSE INFLAMMATION OF THE EYELIDS OF HUMANS. EYE PROTECTION MUST BE WORN WHEN REHYDRATING AND ADMINISTERING THIS VACCINE. AVOID CONTAMINATING HANDS AND CLOTHING WITH THE VACCINE. HAND WASHING IS RECOMMENDED AFTER EXPOSURE TO THE PRODUCT.